Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd

Jubilant Pharmova Ltd (JUBLPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 4,35,584
Apr 25, 2025 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹910.00
₹-42.65 (-4.48%)
901.00Low
Today’s Performance
962.00High
617.05Low
52 Week’s Performance
1,309.90High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-4.48%
  • 1 Week3.67%
  • 1 Month6.51%
  • 3 Months3.30%
  • 6 Months-14.02%
  • 1 Year39.62%
  • 3 Years25.71%
  • 5 Years21.94%

bt_logoPeer Comparison

Jubilant Pharmova Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Cipla Ltd
Price

₹910.00

Jubilant Pharmova Ltd

₹1,787.40

Sun Pharmaceutical Industries Ltd

₹6,012.50

Divis Laboratories Ltd

₹1,525.90

Cipla Ltd

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.90
  • 52-Week Low (₹)617.05
  • 52-Week High (₹)1,309.90
  • Price-to-Book (X)*2.56
  • Dividend Yield (%)0.52
  • Price-to-Earnings (P/E) (X)*24.21
  • Earnings Per Share (₹)39.37
  • Market Cap (₹ Cr.)*15,175.71
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices3:40Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices
Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report19:05Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report
India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop8:47India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop
Market Skittish Ahead Of Possible Indian Military Response To Pahalgam Carnage29:33Market Skittish Ahead Of Possible Indian Military Response To Pahalgam Carnage
How to Secure Growth in the Next Decade: Kenneth Andrade’s Global Portfolio Insights1:30How to Secure Growth in the Next Decade: Kenneth Andrade’s Global Portfolio Insights
US Based Jewellery Brand Angara Enters India | To Open 100 Stores By 2030 | Aditi & Ankur Daga22:02US Based Jewellery Brand Angara Enters India | To Open 100 Stores By 2030 | Aditi & Ankur Daga
India Eyes Trade Gains As Trump Softens Tariff Stance On China2:01India Eyes Trade Gains As Trump Softens Tariff Stance On China
New Tax On Luxury! Helicopters, Handbags & High-End Hobbies Now Cost More5:24New Tax On Luxury! Helicopters, Handbags & High-End Hobbies Now Cost More
Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today46:35Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
China’s ‘Secret Soldiers’ Invade And Turn US Opinion On Tariffs, Target Shoppers3:46China’s ‘Secret Soldiers’ Invade And Turn US Opinion On Tariffs, Target Shoppers
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

bt_logoRatio Analysis

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)
Promoters (50.68%)
Domestic institutional investors (7.05%)
Foreign Institutional Investors (18.41%)
Public & Others (20.59%)
Government Holding (0.00%)
Corporate Holding (3.28%)

bt_logoDeals

19 Sep, 2022SELL
ISHARES CORE EMERGING MARKETS MAURITIUS CO
Qty683197
Average Price₹313.3
19 Sep, 2022BUY
ISHARES MSCI INDIA SMALL-CAP ETF
Qty84898
Average Price₹313.3
19 Sep, 2022SELL
ISHARES INDIA SC MAURITIUS COMPANY
Qty84898
Average Price₹313.3
19 Sep, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty683197
Average Price₹313.3
26 Aug, 2021BUY
KIFS DEALERS
Qty250000
Average Price₹617
26 Aug, 2021SELL
YESHA DEVELOPERS LLP
Qty250000
Average Price₹617
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Jubilant Pharmova Ltd share price previously?
Jubilant Pharmova Ltd share price was down by -4.48% from the previous closing price of ₹952.65.
Who are peers of Jubilant Pharmova Ltd?
The peers of Jubilant Pharmova Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Jubilant Pharmova Ltd?
The promotor/promotors of Jubilant Pharmova Ltd are Shyam S Bhartia, Hari S Bhartia, Vivek Mehra, SUSHIL KUMAR ROONGTA, Priyavrat Bhartia, Arjun Shanker Bhartia, Arun Seth, Arvind Chokhany, Naresh Kapoor, Shirish Gundopant Belapure, Ramakrishnan Arul, Harsh Mahajan, Shivpriya Nanda.
What has been 52-week high of Jubilant Pharmova Ltd stocks?
The highest price of Jubilant Pharmova Ltd stock is ₹1,309.90 in the last 52-week.
What is the share price of Jubilant Pharmova Ltd (JUBLPHARMA) today on NSE?
As on Apr 25, 2025 Jubilant Pharmova Ltd (JUBLPHARMA)’s share price on NSE is Rs 910
What is the market cap of Jubilant Pharmova Ltd (JUBLPHARMA)?
The current market capitalisation of Jubilant Pharmova Ltd (JUBLPHARMA) is 15,175.71 crores
What is Jubilant Pharmova Ltd Share symbol?
The symbol of Jubilant Pharmova Ltd is JUBLPHARMA.
What is the PE ratio of Jubilant Pharmova Ltd (JUBLPHARMA)?
The current PE ratio of Jubilant Pharmova Ltd (JUBLPHARMA) is 24.21.
What is the PB ratio of Jubilant Pharmova Ltd (JUBLPHARMA)?
The current PB ratio of Jubilant Pharmova Ltd (JUBLPHARMA) is 2.56.
Today’s High & Low share prices of Jubilant Pharmova Ltd (JUBLPHARMA) on NSE?
Today, the share price of Jubilant Pharmova Ltd (JUBLPHARMA) on NSE touched a high of Rs 962 and a low of Rs 901
What price did Jubilant Pharmova Ltd (JUBLPHARMA) shares open on the NSE today?
On NSE, the share price of Jubilant Pharmova Ltd (JUBLPHARMA) opened at Rs 958
What is the 52-week high of Jubilant Pharmova Ltd (JUBLPHARMA)?
The 52-week high price of Jubilant Pharmova Ltd (JUBLPHARMA) is Rs 1,309.90
What is the 52-week low of Jubilant Pharmova Ltd (JUBLPHARMA)?
The 52-week low price of Jubilant Pharmova Ltd (JUBLPHARMA) is Rs 617.05

bt_logoAbout Jubilant Pharmo

Jubilant Pharmova Ltd, incorporated in the year 1978, has its registered office in Bhartiagram Gajraula, Amroha, Uttar Pradesh, 244223, 91-5924-267200, 91-5924-4264895/96. The main industry in which Jubilant Pharmova Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Jubilant Pharmova Ltd is/are Walker Chandiok & Co LLP. In the main management, Shyam S Bhartia is chairman and Naresh Kapoor is the company secretary for Jubilant Pharmova Ltd.

  • SSB
    Shyam S BhartiaChairman (Non-Executive)
  • HSB
    Hari S BhartiaCo-Chairman & Non-Exe.Director
  • VM
    Vivek MehraNon-Exec. & Independent Dir.
  • SKR
    SUSHIL KUMAR ROONGTANon-Exec. & Independent Dir.
  • PB
    Priyavrat BhartiaManaging Director
  • ASB
    Arjun Shanker BhartiaJoint Managing Director
  • AS
    Arun SethNon-Exec. & Independent Dir.
  • AC
    Arvind ChokhanyWhole Time Director & CFO
  • NK
    Naresh KapoorCompany Sec. & Compli. Officer
  • SGB
    Shirish Gundopant BelapureIndependent Director
  • RA
    Ramakrishnan ArulWhole-time Director
  • HM
    Harsh MahajanIndependent Director
  • SN
    Shivpriya NandaIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.